The deadline for sending the letter of intent to email@example.com is exceptionaly extended to the 18 of February 2022. An e-mail confirming that we received your application will be adressed to you. Please contact us if you do not receive this confirmation.
In 2022 IFCAH (International Fund raising for Congenital Adrenal Hyperplasia) and ESPE (European society for pediatric endocrinology) launches its call for proposals.
Academic groups working directly or indirectly on CAH are invited to submit a project if the results of their studies could help to increase knowledge on physiopathology of the disease or allow a better therapeutic approach.
Participation is open worldwide and should, if possible, include teams based in Europe.
This restriction does not apply to projects on gene or cellular therapies of the disease.
Selection procedures will include 2 steps:
The information given on letter of intent (LOI) will enable the scientific board of IFCAH-ESPE to access the priority of the projects and to determine whether the proposed research merits a full application. Full applications will be requested from selected LOIs and submitted to peer-review.
Final selection will take place after an oral project’s presentation (on site in Paris or through video-conference) to the IFCAH-ESPE scientific board.
18 of February 2022 (exceptional extension): Due date for sending the letter of intention (LOI)
February 2022: LOI decision meeting
April 2022: Full application due date (for accepted LOIs)
June 2022: Audition of proposals
July 2022: Award notification